This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Reason: Acquired by Amgen
Last recorded trade on: December 8, 2023
Source: https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html
Horizon Therapeutics
HZNP
$116.30
Share price
0.00%
Change (1 day)
5.68%
Change (1 year)
Categories
Horizon Therapeutics (HZNP) Fails to deliver data
Key failure to deliver metrics for Horizon Therapeutics :
- Last SEC data release: 2024-09-13
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Horizon Therapeutics (HZNP) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Horizon Therapeutics (HZNP) - since 2019
Volume in USD (price x number of shares), data since 2019Horizon Therapeutics (HZNP) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $18.33 M | -79.41% |
| 2022 | $89.06 M | -30.85% |
| 2021 | $0.12 B | 203.1% |
| 2020 | $42.49 M | 362.79% |
| 2019 | $9.18 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | $97.9 M | $0.29 B | 🇺🇸 USA |
 | $38.09 M | $0.13 B | 🇬🇧 UK |
 | $32.79 M | $0.34 B | 🇺🇸 USA |
 | $1.95 M | $8.69 M | 🇮🇳 India |
 | $0.10 B | $0.17 B | 🇺🇸 USA |